|
2005 Journal Article Tissue-engineered blood vessels: Alternative to autologous grafts?Hoenig, Michel R., Campbell, Gordon R., Rolfe, Barbara E. and Campbell, Julie H. (2005). Tissue-engineered blood vessels: Alternative to autologous grafts?. Arteriosclerosis, Thrombosis, and Vascular Biology, 25 (6), 1128-1134. doi: 10.1161/01.ATV.0000158996.03867.72 |
|
2005 Journal Article Rho and vascular diseaseRolfe, B. E., Worth, N. F., World, C. J., Campbell, J. H. and Campbell, G. R. (2005). Rho and vascular disease. Atherosclerosis, 183 (1), 1-16. doi: 10.1016/j.atherosclerosis.2005.04.023 |
|
2005 Conference Publication Artifical arteries from cells of bone marrow originCampbell, J. H., Efendy, J., Chue, W., Daly, C., Mooney, J., Zhang, B., Rolfe, B., Walker, P. and Campbell, G. R. (2005). Artifical arteries from cells of bone marrow origin. Vascular 2005, Sydney, 9-14 Sep, 2005. |
|
2004 Journal Article Rho expression and activation in vascular smooth muscle cellsWorth, N. F., Campbell, G. R., Campbell, J. H. and Rolfe, B. E. (2004). Rho expression and activation in vascular smooth muscle cells. Cell Motility and the Cytoskeleton, 59 (3), 189-200. doi: 10.1002/cm.20036 |
|
2004 Journal Article THE THERAPEUTIC ACTIONS OF LIF ON THE VASCULATUREWorld, Cameron, Rolfe, Barbara and Campbell, Julie (2004). THE THERAPEUTIC ACTIONS OF LIF ON THE VASCULATURE. Cardiovascular Pathology, 13 (3), 61. doi: 10.1016/j.carpath.2004.03.179 |
|
2004 Conference Publication Rho and smooth muscle cell phenotypeWorth, N.F., Rolfe, B.E., Campbell, J.H. and Campbell, G.R. (2004). Rho and smooth muscle cell phenotype. Thirteenth International Symposium on Atherosclerosis, Kyoto, Japan, 27 September - 3 October 2003. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/S0531-5131(03)01863-6 |
|
2004 Journal Article The effects of leukemia inhibitory factor (LIF) on neointimal formation in injured arteriesWorld, C.J., Merrilees, M.J., Beaumont, B., Campbell, G. R., Campbell, J. H. and Rolfe, B. E. (2004). The effects of leukemia inhibitory factor (LIF) on neointimal formation in injured arteries. Biomedical Research, 15 (2), 169-175. |
|
2003 Conference Publication Rho and smooth muscle cell phenotypeWorth, N. F., Rolfe, B. E. and Campbell, G. R. (2003). Rho and smooth muscle cell phenotype. 13th International Atherosclerosis Symposium, Kyoto, Japan, 28 September - 2 October 2004. Amsterdam, The Netherlands: Elsevier. doi: 10.1016/S1567-5688(03)90774-4 |
|
2003 Journal Article Leukaemia inhibitory factor retards the progression of atherosclerosisRolfe, Barbara E., Stamatiou, Steve, World, Cameron J., Brown, Lindsay, Thomas, Anita C., Bingley, John A., Worth, Nathalie F. and Campbell, Julie H. (2003). Leukaemia inhibitory factor retards the progression of atherosclerosis. Cardiovascular Research, 58 (1), 222-230. doi: 10.1016/S0008-6363(02)00832-5 |
|
2003 Journal Article Rho and smooth muscle cell phenotypeWorth, N. F., Rolfe, B. E., Campbell, J. H. and Campbell, G. R. (2003). Rho and smooth muscle cell phenotype. International Congress Series, 1262 (C), 111-114. doi: 10.1016/S0531-5131(03)01863-6 |
|
2001 Journal Article Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteinsWorth, N. F., Rolfe, B. E., Song, J. and Campbell, G. R. (2001). Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins. Cell Motility And The Cytoskeleton, 49 (3), 130-145. doi: 10.1002/cm.1027 |
|
2001 Conference Publication Rho as a regulator of smooth muscle phenotypeRolfe, B. E., Worth, N.F. and Campbell, G. R. (2001). Rho as a regulator of smooth muscle phenotype. COMBIO, Canberra, October 2001. |
|
2001 Conference Publication Attenuation of smooth muscle proliferation by leukaemia inhibitory factor involves the activation of negative feed-back regulatorsWorld, C., Rolfe, B. E. and Campbell, J. H. (2001). Attenuation of smooth muscle proliferation by leukaemia inhibitory factor involves the activation of negative feed-back regulators. COMBIO, Canberra, October 2001. |
|
2001 Journal Article Reorganization of structural proteins in vascular smooth muscle cells grown in collagen gel and basement membrane matrices (Matrigel): A comparison with their in situ counterpartsSong, J., Rolfe, B. E., Hayward, I. P., Campbell, G. R. and Campbell, J. H. (2001). Reorganization of structural proteins in vascular smooth muscle cells grown in collagen gel and basement membrane matrices (Matrigel): A comparison with their in situ counterparts. Journal of Structural Biology, 133 (1), 43-54. doi: 10.1006/jsbi.2001.4327 |
|
2001 Conference Publication Smooth muscle, the cytoskeleton and cell signallingWorth, N.F., Rolfe, B. E. and Campbell, G. R. (2001). Smooth muscle, the cytoskeleton and cell signalling. Australian Vascular Biology Society 9th Scientific Annual Meeting, Noosa, Qld, 30 August - 2 September 2001. |
|
2001 Conference Publication A role for Rho in smooth muscle phenotypic regulationCampbell, G. R., Worth, N. F. and Rolfe, B. E. (2001). A role for Rho in smooth muscle phenotypic regulation. Australian Vascular Biology Society, Noosa, Queensland, Australia, Ausgust, 2001. New York: The Academy. |
|
2001 Conference Publication A role for Rho in smooth muscle phenotypic regulationWorth, N. F., Campbell, G. R. and Rolfe, B. E. (2001). A role for Rho in smooth muscle phenotypic regulation. 6th Saratoga International Conference on Atherosclerosis, Tokyo, Japan, 3-6 April 2001. Malden, MA United States: Wiley-Blackwell. doi: 10.1111/j.1749-6632.2001.tb03955.x |
|
2001 Journal Article Regulation of LIF receptor expression in vascular smooth muscleWorld, C., Rolfe, B. E. and Campbell, J. H. (2001). Regulation of LIF receptor expression in vascular smooth muscle. Annals of the New York Academy of Sciences, 947 (1), 323-328. doi: 10.1111/j.1749-6632.2001.tb03956.x |
|
2001 Conference Publication The signal attenuating effects of LIF treated vascular smooth muscle cells as a means of inhibiting hyperplasiaWorld, C., Rolfe, B. E. and Campbell, J. H. (2001). The signal attenuating effects of LIF treated vascular smooth muscle cells as a means of inhibiting hyperplasia. Australian Vascular Biology Society 9th Annual Scientific Meeting, Noosa Qld, 30 August - September 2, 2001. |
|
2000 Journal Article ICAM-1expression by vascular smooth muscle cells is phenotype-dependentRolfe, B. E., Muddiman, J. D., Smith, N. J., Campbell, G. R. and Campbell, J. H. (2000). ICAM-1expression by vascular smooth muscle cells is phenotype-dependent. Atherosclerosis, 149 (1), 99-110. doi: 10.1016/S0021-9150(99)00322-6 |
